CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia
- Resource Type
- Source
- Nature Medicine. 28:1573-1580
- Subject
General Medicine General Biochemistry, Genetics and Molecular Biology - Language
- ISSN
- 1546-170X
1078-8956